Baxter International Inc. (NYSE:BAX) shares reached a new 52-week high on Thursday . The stock traded as high as $49.38 and last traded at $49.31, with a volume of 2,000,236 shares. The stock had previously closed at $48.60.

Several analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their target price on shares of Baxter International from $45.00 to $48.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 27th. Zacks Investment Research upgraded shares of Baxter International from a “sell” rating to a “hold” rating and set a $54.00 target price for the company in a research note on Wednesday, July 27th. RBC Capital Markets reiterated a “hold” rating and issued a $50.00 target price (up previously from $47.00) on shares of Baxter International in a research note on Wednesday, July 27th. Royal Bank Of Canada upped their target price on shares of Baxter International from $47.00 to $50.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 27th. Finally, Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Baxter International in a research note on Wednesday, July 6th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $47.91.

The firm has a market cap of $26.43 billion and a price-to-earnings ratio of 5.58. The company’s 50 day moving average is $46.78 and its 200-day moving average is $42.93.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Tuesday, July 26th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.40 by $0.06. The business earned $2.60 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the previous year, the business posted $1.00 earnings per share. Baxter International’s quarterly revenue was up 4.4% compared to the same quarter last year. On average, analysts anticipate that Baxter International Inc. will post $1.72 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 3rd. Investors of record on Friday, September 2nd will be issued a $0.13 dividend. The ex-dividend date is Wednesday, August 31st. This represents a $0.52 annualized dividend and a yield of 1.07%.

In other Baxter International news, CEO Jose E. Almeida acquired 11,691 shares of Baxter International stock in a transaction that occurred on Monday, May 23rd. The stock was bought at an average cost of $42.75 per share, for a total transaction of $499,790.25. Following the acquisition, the chief executive officer now owns 11,691 shares of the company’s stock, valued at $499,790.25. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

A number of large investors have added to or reduced their stakes in BAX. Mutual of America Capital Management LLC increased its stake in Baxter International by 1.0% in the fourth quarter. Mutual of America Capital Management LLC now owns 61,116 shares of the company’s stock valued at $2,332,000 after buying an additional 625 shares during the last quarter. Airain ltd increased its stake in Baxter International by 82.5% in the fourth quarter. Airain ltd now owns 197,303 shares of the company’s stock worth $7,527,000 after buying an additional 89,170 shares in the last quarter. Finally, Argent Capital Management LLC purchased a new stake in Baxter International during the fourth quarter worth about $40,732,000.

Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.